Actress Rebel Wilson pairs GLP-1s and healthy habits to lose weight 'for keeps' in new Noom campaign
The campaign is one of weight loss app Noom's largest brand investment to date and features two TV spots and new in-app ...
From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites ...
With two approved medicines to treat primary immunoglobulin A nephropathy (IgAN) and a third therapy in phase 3 testing, ...
Since reaching the market a decade ago, PCSK9 inhibitors have not lived up to their lofty expectations. | The FDA has ...
As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new ...
Antibody-drug conjugates from Kelun-Biotech and Hansoh Pharma, respectively partnered with Merck & Co. and GSK, delivered positive phase 3 readouts in China. AstraZeneca reached out to its spinout, ...
Kelun scores sac-TMT win in first-line NSCLC population missing from Merck’s massive phase 3 program
The clinical blueprint for Merck & Co.’s prized TROP2-directed antibody-drug conjugate, sacituzumab tirumotecan (sac-TMT), ...
Red-hot generative AI specialist Insilico Medicine has teamed up with another major biopharma player, this time linking up ...
A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ ...
Huyabio has scored a win in the largest oncology study it has undertaken in its 22 years, as its oral histone deacetylase ...
Zhejiang Huahai Pharmaceutical has hired a former FDA staffer as its new chief quality officer, as the company struggles to resolve compliance issues with the FDA at a key manufacturing facility.
Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results